Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| Ovarian high-grade serous carcinoma with elevated β-human chorionic gonadotropin: A case report. | Medicine (Baltimore) | 2021 | 34941061 | PubTator, text mining | PubMed |
| Mean square displacement for a discrete centroid model of cell motion. | PLoS One | 2021 | 34928985 | PubTator, text mining | PubMed |
| Germline Mutation Landscape and Associated Clinical Characteristics in Chinese Patients With Renal Cell Carcinoma. | Front Oncol | 2021 | 34926252 | PubTator, text mining | PubMed |
| Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types. | Clin Transl Med | 2021 | 34923755 | PubTator, text mining | PubMed |
| Glyoxal damages human aortic endothelial cells by perturbing the glutathione, mitochondrial membrane potential, and mitogen-activated protein kinase pathways. | BMC Cardiovasc Disord | 2021 | 34922451 | PubTator, text mining | PubMed |
| Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. | Front Genet | 2021 | 34917121 | PubTator, text mining | PubMed |
| Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer With Non-BRCA Mutations. | Front Pharmacol | 2021 | 34912215 | PubTator, text mining | PubMed |
| MRE11-dependent instability in mitochondrial DNA fork protection activates a cGAS immune signaling pathway. | Sci Adv | 2021 | 34910513 | PubTator, text mining | PubMed |
| gcMECM: graph clustering of mutual exclusivity of cancer mutations. | BMC Bioinformatics | 2021 | 34906079 | PubTator, text mining | PubMed |
| PARP Inhibitors in Pancreatic Cancer. | Cancer J | 2021 | 34904809 | PubTator, text mining | PubMed |
| Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression. | Epigenetics Chromatin | 2021 | 34895312 | PubTator, text mining | PubMed |
| An Early-Onset Advanced Rectal Cancer Patient With Increased KRAS Gene Copy Number Showed A Primary Resistance to Cetuximab in Combination With Chemotherapy: A Case Report. | Front Oncol | 2021 | 34888240 | PubTator, text mining | PubMed |
| Endocrinopathies in Inborn Errors of Immunity. | Front Immunol | 2021 | 34887872 | PubTator, text mining | PubMed |
| Multiparametric Circulating Tumor Cell Analysis to Select Targeted Therapies for Breast Cancer Patients. | Cancers (Basel) | 2021 | 34885114 | PubTator, text mining | PubMed |
| Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma. | Cancers (Basel) | 2021 | 34885093 | PubTator, text mining | PubMed |
| DNA Repair Genes as Drug Candidates for Early Breast Cancer Onset in Latin America: A Systematic Review. | Int J Mol Sci | 2021 | 34884835 | PubTator, text mining | PubMed |
| Focal Point of Fanconi Anemia Signaling. | Int J Mol Sci | 2021 | 34884777 | PubTator, text mining | PubMed |
| BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations. | Int J Mol Sci | 2021 | 34884434 | PubTator, text mining | PubMed |
| A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening. | Front Bioeng Biotechnol | 2021 | 34869264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=59